MacroGenics strikes commercialization deal with Eversana ahead of potential Food and Drug Administration approval for breast cancer treatment - Washington Business Journal

The agency's decision is expected to drop Dec. 18.

Image: MacroGenics is led by CEO and co-founder Scott Koenig. JOANNE S. LAWTON